TapImmune, Inc. (TPIV.OB) is “One to Watch”

By Jonathan
20 November 2009 @ 05:40 am EDT

TapImmune, Inc. is a biotechnology company focused on developing innovative therapeutics and vaccines in the areas of oncology and infectious disease. The company’s lead product, the TAP vaccine, moves characteristic markers called antigens to the surfaces of cells. Without TAP, there are no cancer markers, making it impossible for the immune system to spot rogue cells and cancerous cells, allowing them to grow undetected.

Small Cap News in collaboration with Quality Stocks

E-Newsletters

We value your privacy. Your email address will not be shared.